Paul Tudor Jones’s Epizyme, Inc EPZM Stock Holding History

Paul Tudor Jones’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-218,384	Closed	-$324K	–	2249
2022 Q2	$321K	Hold	218,384	–	–	0.01%	1519
2022 Q1	$251K	Buy	218,384 +75,737	+53%	+$123K	0.01%	1650
2021 Q4	$357K	Buy	+142,647	New	+$560K	0.01%	1719
2021 Q1	–	Sell	-112,644	Closed	-$1.22M	–	1944
2020 Q4	$1.22M	Buy	112,644 +50,650	+82%	+$625K	0.03%	615
2020 Q3	$740K	Buy	+61,994	New	+$830K	0.03%	669
2019 Q4	–	Sell	-27,201	Closed	-$281K	–	1446
2019 Q3	$281K	Sell	27,201 -16,678	-38%	-$210K	0.01%	875
2019 Q2	$551K	Buy	43,879 +3,396	+8%	+$43.7K	0.02%	680
2019 Q1	$502K	Buy	40,483 +8,179	+25%	+$91.4K	0.02%	713
2018 Q4	$199K	Buy	32,304 +15,176	+89%	+$116K	﹤0.01%	872
2018 Q3	$182K	Sell	17,128 -8,810	-34%	-$101K	﹤0.01%	982
2018 Q2	$351K	Buy	+25,938	New	+$404K	0.01%	770
2017 Q4	–	Sell	-40,943	Closed	-$780K	–	1345
2017 Q3	$780K	Buy	40,943 +26,716	+188%	+$408K	0.02%	478
2017 Q2	$215K	Buy	+14,227	New	+$215K	0.01%	865

Paul Tudor Jones's EPZM Position: Q3 2022 in Review

Paul Tudor Jones sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 218,384 shares — an estimated $324K sold.

Paul Tudor Jones first reported a position in EPZM in Q2 2017 and held it in 13 quarters. The position peaked at $1.22M in Q4 2020. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Paul Tudor Jones reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Paul Tudor Jones sold 218,384 Epizyme, Inc shares in Q3 2022, an estimated $324K.
Paul Tudor Jones first reported a position in Epizyme, Inc in Q2 2017 and held it in 13 quarters.
Paul Tudor Jones's Epizyme, Inc position peaked at $1.22M in Q4 2020.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Tudor Investment Corp's 13F filing for Q3 2022, filed 14 Nov 2022.